Specificity of the T Cell Response to Protein Biopharmaceuticals

Protein biopharmaceuticals (BPs) have revolutionized the treatment of many diseases and their share of the worldwide drug market continues to grow. There are three main categories of protein BPs, if we exclude recombinant vaccines and allergen-specific immunotherapy.